Hi @hottod,
I also reckon Ch18 conditions (including monosomy, trisomy (Edwards), p- and other) would not only meet the orphan criteria and also could benefit favourably from NEU attention and NNZ2591.
Neuren Media and Analyst Coverage, page-1223
-
- There are more pages in this discussion • 178 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.03 |
Change
0.760(6.19%) |
Mkt cap ! $1.568B | |||
| Open | High | Low | Value | Volume |
| $12.95 | $13.09 | $12.79 | $1.349M | 104.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 200 | $13.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.04 | 90 | 2 |
View Market Depth
| Last trade - 10.26am 06/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |